Sunshine Guojian Pharmaceutical (Shanghai) Co (SHSE:688336) Inventories, Raw Materials & Components: ¥101 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:688336 Sunshine Guojian Pharmaceutical (Shanghai) Co Ltd SHSE:688336
82 GF Score
Price ¥47.65
GF Value ¥66.01
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is Sunshine Guojian Pharmaceutical (Shanghai) Co Inventories, Raw Materials & Components?

Sunshine Guojian Pharmaceutical (Shanghai) Co SHSE:688336 -1.97% 82 Inventories, Raw Materials & Components is ¥101 Mil as of Jun. 2026. GuruFocus rates SHSE:688336 with a GF Score™ of 82/100 and a GF Value™ of ¥66.01 (Modestly Undervalued). The stock has 3 warning signs investors should review.

Sunshine Guojian Pharmaceutical (Shanghai) Co's inventories, raw materials & components for the quarter that ended in Jun. 2026 was ¥101 Mil.

Sunshine Guojian Pharmaceutical (Shanghai) Co's quarterly raw materials declined from Dec. 2025 (¥83 Mil) to Mar. 2026 (¥0 Mil) but then increased from Mar. 2026 (¥0 Mil) to Jun. 2026 (¥101 Mil).

Sunshine Guojian Pharmaceutical (Shanghai) Co's annual raw materials declined from Dec. 2023 (¥79 Mil) to Dec. 2024 (¥73 Mil) but then increased from Dec. 2024 (¥73 Mil) to Dec. 2025 (¥83 Mil).

Sunshine Guojian Pharmaceutical (Shanghai) Co Inventories, Raw Materials & Components Historical Data

* Premium members only.

The historical data trend for Sunshine Guojian Pharmaceutical (Shanghai) Co's Inventories, Raw Materials & Components can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sunshine Guojian Pharmaceutical (Shanghai) Co Inventories, Raw Materials & Components Chart

Sunshine Guojian Pharmaceutical (Shanghai) Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Inventories, Raw Materials & Components
Get a 7-Day Free Trial Premium Member Only Premium Member Only 92.64 98.56 79.31 73.03 82.89

Sunshine Guojian Pharmaceutical (Shanghai) Co Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Inventories, Raw Materials & Components Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 57.02 0.00 82.89 0.00 100.77
SHSE:688336
82GF Score
Sunshine Guojian Pharmaceutical (Shanghai) Co Ltd SHSE:688336
Inventories, Raw Materials & Components is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sunshine Guojian Pharmaceutical (Shanghai) Co Inventories, Raw Materials & Components Calculation

Materials and components scheduled for use in making a product.

What does a Inventories, Raw Materials & Components of ¥101 Mil mean?
Sunshine Guojian Pharmaceutical (Shanghai) Co (SHSE:688336) has a Inventories, Raw Materials & Components of ¥101 Mil as of Jun. 2026. Raw materials are the components a company uses for its main products. View historical data on Sunshine Guojian Pharmaceutical (Shanghai) Co and its competitors.
Is Sunshine Guojian Pharmaceutical (Shanghai) Co's Inventories, Raw Materials & Components too high?
Sunshine Guojian Pharmaceutical (Shanghai) Co's current Inventories, Raw Materials & Components is ¥101 Mil. Overall, Sunshine Guojian Pharmaceutical (Shanghai) Co has a GF Score™ of 82/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Sunshine Guojian Pharmaceutical (Shanghai) Co's Inventories, Raw Materials & Components compare to VRTX and REGN?
Sunshine Guojian Pharmaceutical (Shanghai) Co's Inventories, Raw Materials & Components of ¥101 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Inventories, Raw Materials & Components for a Biotechnology company?
A good Inventories, Raw Materials & Components depends on the Biotechnology industry context. However, Inventories, Raw Materials & Components should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Inventories, Raw Materials & Components mean?
A high Inventories, Raw Materials & Components can signal that a stock is expensive relative to its fundamentals. Raw materials are the components a company uses for its main products. View historical data on Sunshine Guojian Pharmaceutical (Shanghai) Co and its competitors. Sunshine Guojian Pharmaceutical (Shanghai) Co's current Inventories, Raw Materials & Components is ¥101 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sunshine Guojian Pharmaceutical (Shanghai) Co stock overvalued right now?
Based on GuruFocus' analysis, Sunshine Guojian Pharmaceutical (Shanghai) Co (SHSE:688336) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥66.01, compared to a current price of ¥47.65 — trading 27.8% below its estimated fair value. The current Inventories, Raw Materials & Components is ¥101 Mil. Sunshine Guojian Pharmaceutical (Shanghai) Co's overall GF Score™ is 82/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Inventories, Raw Materials & Components calculated?
Inventories, Raw Materials & Components is calculated from a company's financial statements. For Sunshine Guojian Pharmaceutical (Shanghai) Co (SHSE:688336), the current Inventories, Raw Materials & Components is ¥101 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Sunshine Guojian Pharmaceutical (Shanghai) Co (SHSE:688336) Overvalued in 2026?

Based on GuruFocus' analysis, Sunshine Guojian Pharmaceutical (Shanghai) Co stock appears to be undervalued. The current stock price of ¥47.65 is trading 27.8% below its estimated GF Value™ of ¥66.01. GuruFocus considers Sunshine Guojian Pharmaceutical (Shanghai) Co to be Modestly Undervalued.

Key valuation signals for SHSE:688336:

  • Inventories, Raw Materials & Components: ¥101 Mil
  • GF Value™: ¥66.01 vs. price of ¥47.65 (27.8% below fair value)
  • GF Score™: 82/100 with 3 warning signs

No single metric tells the full story. See the SHSE:688336 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Sunshine Guojian Pharmaceutical (Shanghai) Co Business Description

Address No.399 Libing Road, China (Shanghai) Pilot Free Trade Zone, Shanghai, CHN, 201203
Sunshine Guojian Pharmaceutical (Shanghai) Co Ltd is a biopharmaceutical company providing safe and effective clinical solutions for the treatment of major diseases such as autoimmune diseases and tumors. The company engages in in research and development, manufacturing and commercialization of therapeutic antibody drugs in China. Its products portfolio includes YISAIPU and Xenopax. Its products in pipeline include 302H, 304R, 602, 601A, 609A and 301S.
82GF Score

Get the complete analysis for SHSE:688336

Inventories, Raw Materials & Components is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥47.65
Price
¥66.01
GF Value